Predictors of physical functioning among adults with severe mental illness

Psychiatric Services

Volumn 57, Issue 2, 2006, Pages 225-231

  Chafetz, Linda ^a   White, Mary C ^a   Collins Bride, Gerri ^a   Nickens, John ^b   Cooper, Bruce A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Progress Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; OPIATE; PSYCHOSTIMULANT AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; CIGARETTE SMOKING; DEPRESSION; DISEASE SEVERITY; DRUG ABUSE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OPIATE ADDICTION; PSYCHIATRIC DIAGNOSIS; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL MODEL;

EID: 32244448745     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.57.2.225     Document Type: Article

References (53)

1. Harris EC, Barraclough B: Excess mortality of mental disorder. British Journal of Psychiatry 173:11-53 1998
2. White MC, Tulsky JP, Dawson C, et al: Association between time homeless and perceived health status among the homeless in San Francisco. Journal of Community Health 22:271-282, 1997
3. Cohen DA, Mason K, Bedimo A, et al: Neighborhood physical conditions and health. American Journal of Public Health 93:467-471, 2003
4. Williams JM, Ziedonis D: Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behavior 29:1067-1083, 2004
5. Susce MT, Villaneuva N, Diaz JD, et al: Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. Journal of Clinical Psychiatry 66:167-173, 2005
6. RachBeisel J, Scott J, Dixon L: Cooccurring severe mental illness and substance use disorders: a review of recent research. Psychiatric Services 50:1427-1434, 1999
7. Blank MB, Mandell DS, Aik-en L, et al: Cooccurrence of HIV and serious mental illness among Medicaid recipients. Psychiatric Services 53:868-873, 2002
8. Essock SM, Dowden S, Constantine NT, et al: Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatric Services 54:836-841, 2003
9. Osher FC, Goldberg RW, McNary SW, et al: Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatric Services 54:842-847, 2003
10. Carney RM, Freedland KE, Miller GE, et al: Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. Journal of Psychosomatic Research 53:897-902, 2002
11. Eaton WW: Epidemiologic evidence on the comorbidity of depression and diabetes. Journal of Psychosomatic Research 53:903-906, 2002
12. Ryan MC, Collins P, Thakore JH: Impaired fasting glucose tolerance in first episode, drug naive patients with schizophrenia. American Journal of Psychiatry 160:284-289, 2003
13. Ryan MC. Thakore JH: Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sciences 71:239-257, 2002
14. Cohn T, Prud'homme D, Streiner D, et al: Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Canadian Journal of Psychiatry 49:753-60, 2004
15. Schwartz TL, Nihalani N, Jindal S, et al: Psychiatric medication induced obesity: a review. Obesity Review 5:115-121, 2004
16. Fontaine KR, Heo M, Harrigan EP, et al: Estimating the consequences of antipsychotic induced weight gain on health and mortality rate. Psychiatry Research 101:277-288, 2001
17. Wirshing DA, Pierre JM, Erhart SM, et al: Understanding the new and evolving profile of adverse drug effects in schizophrenia. Psychiatric Clinics of North America 26:165-190, 2003
18. Calabrese JR, Kasper S, Johnson G, et al: International Consensus Group on Bipolar I: depression treatment guidelines. Journal of Clinical Psychiatry 65:571-579, 2004
19. McElroy SL, Frye MA, Suppes T, et al; Correlates of overweight and obesity in 644 patients with bipolar disorder. Journal of Clinical Psychiatry 63:207-213, 2002
20. Himmelhoch S, Lehman H, Kreyenbuhl J, et al: Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. American Journal of Psychiatry 161:2317-2319, 2004
21. Daumit GL, Pratt LA, Crum RM, et al: Characteristics of primary care visits for individuals with severe mental illness in a national sample. General Hospital Psychiatry 24:391-395, 2002
22. Curkendal SM, Mo J, Classe DB, et al: Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. Journal of Clinical Psychiatry 65:715-720, 2004
23. Dickey B, Normand SL, Weiss RD, et al: Medical morbidity, mental illness, and substance use disorders. Psychiatric Services 53:861-867, 2002
24. Chafetz L, White MC, Collins Bride G, et al: The poor health of the severely mentally ill. Community Mental Health Journal 41:169-184, 2005
25. Hannerz H, Borga P: Mortality among persons with a history as psychiatric inpatients with functional psychosis. Social Psychiatry Psychiatric Epidemiology 35:380-387, 2000
26. Osby U, Correia N, Brandt L, et al: Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophrenia Research 45:21-28, 2000
27. Hoyer EH, Mortensen PB, Olesen AV: Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. British Journal of Psychiatry 176:76-82, 2000
28. Hansen V, Jacobsen BK, Arnesen E: Cause-specific mortality in psychiatric patients after deinstitutionalisation. British Journal of Psychiatry 179:438-443, 2001
29. Lawrence DM, Holman CD, Jablensky AV, et al: Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. British Journal of Psychiatry 182:31-36, 2003
30. Brown S, Inskip H, Barraclough B: Causes of the excess mortality of schizophrenia. British Journal of Psychiatry 177:212-217, 2000
31. Fields SL: Progress Foundation, San Francisco, in Alternatives to the Hospital for Acute Psychiatric Treatment. Edited by Warner R: Washington, DC, American Psychiatric Press, 1995
32. McLellan AT, Luborsky L, Cacciola J, et al: New data from the Addiction Severity Index: reliability and validity in three centers. Journal of Nervous and Mental Disease 173:412-423, 1985
33. Ware JE Jr, Snow KK; Kosinski M: SF36(R) Health Survey: Manual and Interpretation Guide. Lincoln, RI, Quality-Metric, 2000
34. Sciolla A, Patterson TL, Wetherell JL, et al: Functioning and wellbeing of middle aged and older patients with schizophrenia: measurement with the 36item ShortForm (SF36) Health Survey. American Journal of Geriatric Psychiatry 11:629-637, 2003
35. Pyne JM, Sullivan G, Kaplan R, et al: Comparing the sensitivity of generic effectiveness measures with symptom improvement in persons with schizophrenia. Medical Care 41:208-217, 2003
36. Strassnig M, Brar JS, Ganguli R: Body mass index and quality of life in community dwelling patients with schizophrenia. Schizophrenia Research 62:73-76, 2003
37. Yatham LN, Lecrubier Y, Fieve RR, et al: Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disorders 6:379-385, 2004
38. Leidy NK, Palmer C, Murray M, et al: Health related quality of life assessment in euthymic and depressed patients with bipolar disorder; psychometric performance of four selfreport measures. Journal of Affective Disorders 48:207-214, 1998
39. Arnold LM, Witzeman KA, Swank ML, McElroy SL, Keck PE: Health related quality of life using the SF36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. Journal of Affective Disorders 57:235-239, 2000
40. Kruijshaar ME, Hoeymans N, Bijl RV, et al: Levels of disability in major depression: findings from the Netherlands Mental Health Survey and Incidence Study. Journal of Affective Disorders 77:53-64, 2003
41. Gleason OC, Yates WR, Isbell MD, et al: An open label trial of citalopram for major depression in patients with hepatitis C. Journal of Clinical Psychiatry 63:194-198, 2003
42. Wittchen HU, Carter RM, Pfister H, et al: Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. International Clinical Psychopharmacology 15:319-328, 2000
43. Simon GE, Revieki DA, Grothaus LMA, et al: SF 36 summary scores: are physical and mental health truly distinct? Medical Care 36:567-572, 1998
44. Pukrop R, Schlaak V, Moller Leimkuhler AM, et al: Reliability and validity of Quality of Life assessed by the ShortForm 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression. Psychiatry Research 119:63-79, 2003
45. Ware J: SF36 Update. Spine 25:3130-3139, 2000
46. Russo J, Trujillo CA, Wingerson D, et al: The MOS 36Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients. Medical Care 36:752-756, 1998
47. Maxwell SE, Delaney HD: Designing Experiments and Analyzing Data: A Model Comparison Perspective, 2nd ed. Mahwah, NJ: Erlbaum, 2004
48. Lehman AF, Goldberg R, Dixon LB, et al: Improving employment outcomes for persons with severe mental illness. Archives of General Psychiatry 59:165-172, 2002
49. Barrio C, Yamada AM, Hawthorne W, et al: Ethnic disparities in use of public mental health case management services among patients with schizophrenia. Psychiatric Services 54:1264-1270, 2003
50. Mueser KT, Essock SM, Drake RE, et al: Rural and urban differences in patients with dual diagnosis. Schizophrenia Research 48:93-107, 2001
51. Mueser KT, Sengupta A, Schooler NR, et al: Illness management and recovery: a review of the research. Psychiatric Services 53:1272-1284, 2002
52. Evins AE, Cather C, Rigotti NA, et al: Twoyear follow up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry 65:307-311, 2004
53. Faulkner G, Soundy AA, Lloyd K: Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatrica Scandinavica 108:324-332, 2003